Should Value Investors Buy Nutrien (NTR) Stock?

23.02.26 15:40 Uhr

Werte in diesem Artikel
Aktien

66,46 EUR 2,32 EUR 3,62%

Indizes

PKT PKT

10.007,5 PKT -1,8 PKT -0,02%

33.108,2 PKT 150,3 PKT 0,46%

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.One company to watch right now is Nutrien (NTR). NTR is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock has a Forward P/E ratio of 12.54. This compares to its industry's average Forward P/E of 14.48. Over the last 12 months, NTR's Forward P/E has been as high as 15.98 and as low as 11.92, with a median of 13.47. Investors should also note that NTR holds a PEG ratio of 0.86. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. NTR's industry currently sports an average PEG of 1.39. Within the past year, NTR's PEG has been as high as 1.67 and as low as 0.86, with a median of 1.07.Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. NTR has a P/S ratio of 1.27. This compares to its industry's average P/S of 1.45.These are only a few of the key metrics included in Nutrien's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, NTR looks like an impressive value stock at the moment.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nutrien Ltd. (NTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Nutrien (Ex Potash Agrium)

Analysen zu Nutrien (Ex Potash Agrium)

DatumRatingAnalyst
26.03.2026Nutrien (Ex Potash Agrium) SellUBS AG
13.03.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
03.03.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
20.02.2026Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
19.02.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
DatumRatingAnalyst
13.03.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
20.02.2026Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
19.02.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
20.01.2026Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
11.11.2025Nutrien (Ex Potash Agrium) OverweightJP Morgan Chase & Co.
DatumRatingAnalyst
03.03.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
19.02.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
17.02.2026Nutrien (Ex Potash Agrium) Equal WeightBarclays Capital
16.02.2026Nutrien (Ex Potash Agrium) NeutralUBS AG
16.01.2026Nutrien (Ex Potash Agrium) HoldJefferies & Company Inc.
DatumRatingAnalyst
26.03.2026Nutrien (Ex Potash Agrium) SellUBS AG
18.11.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
09.08.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
23.02.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
07.07.2023Nutrien (Ex Potash Agrium) UnderperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nutrien (Ex Potash Agrium) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen